Logo image of CXT

CRANE NXT CO (CXT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CXT - US2244411052 - Common Stock

49.59 USD
-0.39 (-0.78%)
Last: 1/12/2026, 11:20:58 AM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CXT. CXT was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. While CXT has a great profitability rating, there are quite some concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CXT.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CXT was profitable.
In the past year CXT had a positive cash flow from operations.
In the past 5 years CXT has always been profitable.
CXT had a positive operating cash flow in each of the past 5 years.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

With a decent Return On Assets value of 5.30%, CXT is doing good in the industry, outperforming 72.00% of the companies in the same industry.
CXT has a better Return On Equity (12.74%) than 80.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.69%, CXT is in the better half of the industry, outperforming 78.40% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CXT is above the industry average of 8.82%.
The 3 year average ROIC (13.27%) for CXT is well above the current ROIC(8.69%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROIC 8.69%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 9.80%, CXT belongs to the best of the industry, outperforming 82.40% of the companies in the same industry.
CXT's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 17.59%, CXT belongs to the best of the industry, outperforming 92.80% of the companies in the same industry.
In the last couple of years the Operating Margin of CXT has remained more or less at the same level.
Looking at the Gross Margin, with a value of 43.20%, CXT is in the better half of the industry, outperforming 75.20% of the companies in the same industry.
CXT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CXT is still creating some value.
Compared to 1 year ago, CXT has more shares outstanding
Compared to 1 year ago, CXT has a worse debt to assets ratio.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.09 indicates that CXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CXT (2.09) is worse than 68.80% of its industry peers.
The Debt to FCF ratio of CXT is 6.27, which is on the high side as it means it would take CXT, 6.27 years of fcf income to pay off all of its debts.
CXT has a Debt to FCF ratio of 6.27. This is comparable to the rest of the industry: CXT outperforms 57.60% of its industry peers.
A Debt/Equity ratio of 0.89 indicates that CXT is somewhat dependend on debt financing.
The Debt to Equity ratio of CXT (0.89) is worse than 87.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Altman-Z 2.09
ROIC/WACC0.94
WACC9.28%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CXT has a Current Ratio of 1.26. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
CXT has a worse Current ratio (1.26) than 81.60% of its industry peers.
CXT has a Quick Ratio of 1.26. This is a bad value and indicates that CXT is not financially healthy enough and could expect problems in meeting its short term obligations.
CXT's Quick ratio of 0.94 is on the low side compared to the rest of the industry. CXT is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

CXT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.72%.
CXT shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.61% yearly.
CXT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.30%.
Measured over the past years, CXT shows a small growth in Revenue. The Revenue has been growing by 3.39% on average per year.
EPS 1Y (TTM)-1.72%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%10.34%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%10.31%

3.2 Future

Based on estimates for the next years, CXT will show a small growth in Earnings Per Share. The EPS will grow by 7.04% on average per year.
The Revenue is expected to grow by 7.20% on average over the next years.
EPS Next Y-4.27%
EPS Next 2Y3.38%
EPS Next 3Y7.04%
EPS Next 5YN/A
Revenue Next Year9.22%
Revenue Next 2Y7.97%
Revenue Next 3Y7.2%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.43, CXT is valued correctly.
Based on the Price/Earnings ratio, CXT is valued cheaper than 89.60% of the companies in the same industry.
When comparing the Price/Earnings ratio of CXT to the average of the S&P500 Index (27.19), we can say CXT is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.87, the valuation of CXT can be described as reasonable.
91.20% of the companies in the same industry are more expensive than CXT, based on the Price/Forward Earnings ratio.
CXT is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.92, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.43
Fwd PE 10.87
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 90.40% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 87.20% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.5
EV/EBITDA 9.29
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The decent profitability rating of CXT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.38%
EPS Next 3Y7.04%

5

5. Dividend

5.1 Amount

CXT has a Yearly Dividend Yield of 1.38%. Purely for dividend investing, there may be better candidates out there.
The stock price of CXT dropped by -23.78% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CXT's Dividend Yield is rather good when compared to the industry average which is at 0.47. CXT pays more dividend than 92.00% of the companies in the same industry.
CXT's Dividend Yield is slightly below the S&P500 average, which is at 1.92.
Industry RankSector Rank
Dividend Yield 1.38%

5.2 History

The dividend of CXT is nicely growing with an annual growth rate of 6.42%!
CXT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

24.82% of the earnings are spent on dividend by CXT. This is a low number and sustainable payout ratio.
CXT's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP24.82%
EPS Next 2Y3.38%
EPS Next 3Y7.04%
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (1/12/2026, 11:20:58 AM)

49.59

-0.39 (-0.78%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners114.42%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change1.75%
Market Cap2.85B
Revenue(TTM)1.58B
Net Income(TTM)154.70M
Analysts81.82
Price Target94.28 (90.12%)
Short Float %12.54%
Short Ratio12
Dividend
Industry RankSector Rank
Dividend Yield 1.38%
Yearly Dividend0.64
Dividend Growth(5Y)6.42%
DP24.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.72%
Min EPS beat(2)0.03%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)1.08%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)1.32%
EPS beat(12)10
Avg EPS beat(12)6.53%
EPS beat(16)13
Avg EPS beat(16)6.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)0.56%
Revenue beat(12)6
Avg Revenue beat(12)0.73%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.92%
PT rev (3m)2.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.89%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.86%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.54%
Valuation
Industry RankSector Rank
PE 12.43
Fwd PE 10.87
P/S 1.8
P/FCF 16.5
P/OCF 13.13
P/B 2.35
P/tB N/A
EV/EBITDA 9.29
EPS(TTM)3.99
EY8.05%
EPS(NY)4.56
Fwd EY9.2%
FCF(TTM)3.01
FCFY6.06%
OCF(TTM)3.78
OCFY7.61%
SpS27.5
BVpS21.14
TBVpS-9.06
PEG (NY)N/A
PEG (5Y)N/A
Graham Number43.57
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROCE 12.04%
ROIC 8.69%
ROICexc 9.36%
ROICexgc 34.76%
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
FCFM 10.93%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
ROICexc(3y)14.97%
ROICexc(5y)11.69%
ROICexgc(3y)57.83%
ROICexgc(5y)41.66%
ROCE(3y)18.35%
ROCE(5y)14.1%
ROICexgc growth 3Y39.7%
ROICexgc growth 5YN/A
ROICexc growth 3Y25.58%
ROICexc growth 5YN/A
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
F-Score3
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Debt/EBITDA 2.86
Cap/Depr 43.72%
Cap/Sales 2.8%
Interest Coverage 5.31
Cash Conversion 57.22%
Profit Quality 111.57%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.09
F-Score3
WACC9.28%
ROIC/WACC0.94
Cap/Depr(3y)39.82%
Cap/Depr(5y)33.75%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.89%
Profit Quality(3y)120.27%
Profit Quality(5y)131.76%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.72%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%10.34%
EPS Next Y-4.27%
EPS Next 2Y3.38%
EPS Next 3Y7.04%
EPS Next 5YN/A
Revenue 1Y (TTM)9.3%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%10.31%
Revenue Next Year9.22%
Revenue Next 2Y7.97%
Revenue Next 3Y7.2%
Revenue Next 5YN/A
EBIT growth 1Y-0.68%
EBIT growth 3Y4.76%
EBIT growth 5YN/A
EBIT Next Year18.99%
EBIT Next 3Y13.2%
EBIT Next 5YN/A
FCF growth 1Y-55.34%
FCF growth 3Y-13.25%
FCF growth 5YN/A
OCF growth 1Y-48.89%
OCF growth 3Y-8.23%
OCF growth 5YN/A

CRANE NXT CO / CXT FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 7 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


What is the profitability of CXT stock?

CRANE NXT CO (CXT) has a profitability rating of 7 / 10.


How financially healthy is CRANE NXT CO?

The financial health rating of CRANE NXT CO (CXT) is 2 / 10.


Is the dividend of CRANE NXT CO sustainable?

The dividend rating of CRANE NXT CO (CXT) is 5 / 10 and the dividend payout ratio is 24.82%.